#LpaAwarenessDay #KnowYourLpa #lipoproteina To view or add a comment, sign in Im pleased to share our latest publication in Annual Reports in Medicinal Chemistry: How to reduce side effects of GLP-1 based obesity medications, co-authored with Prof
As GLP-1s reshape consumer behaviorsmaller portions, higher protein, more intentional eatinginnovation has to keep pace
Support from others who are going through the same hard things as you
A gut-focused plan may include: digestive health assessment gut microbiome support probiotics or prebiotics when appropriate digestive enzymes DAO support in selected patients broader gut-healing measures Why this matters: poor digestion can increase symptom sensitivity gut inflammation may affect histamine handling dysbiosis may contribute to immune reactivity a damaged intestinal environment can make food responses harder to control That is one reason mast cell care often overlaps with work on reflux, bloating, cramping, food reactivity, diarrhea, and post-meal symptoms
What Foundayo is, and Why it is Different Foundayo contains orforglipron, a small-molecule, non-peptide GLP-1 receptor agonist
The committee voted 12-0 to approve the bill on Thursday